Description: StageZero Life Sciences Inc., formerly GeneNews Ltd, is a Canada-based company focused on developing and commercializing molecular diagnostic tests for early detection of cancer. It has developed Sentinel Principle platform technology, which determines biomarkers from whole blood. In additional, the Company offers ColonSentry product, it is a blood test to determine an individual’s current risk for having colorectal cancer. It is developing cancer testing kit Aristotle, which is a multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood. The Company is also focused on testing Aristotle application on other disease conditions including neurology, gastroenterology, cardiology, and autoimmune disorders.
Home Page: www.stagezerolifesciences.com
SZLS Technical Analysis
70 East Beaver Creek Road
Richmond Hill,
ON
L4B 3B2
Canada
Phone:
905 209 2030
Officers
| Name | Title |
|---|---|
| Mr. James R. Howard-Tripp | Exec. Chairman & CEO |
| Prof. Choong-Chin Liew | Co-Founder |
| Mr. Warren Whitehead C.M.A., CPA | Chief Accountant |
| Mr. David Suria | Sr. Scientist |
Exchange: TO
Country: CA : Canada
Currency: Canadian Dollar (C$)
| Forward PE: | 3.367 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.6184 |
| Price-to-Sales TTM: | 1.5381 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 80 |